James C. Garbutt
Affiliations: | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Pharmacological treatment of alcoholismGoogle:
"James Garbutt"Mean distance: 106866 (cluster 13)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kampov-Polevoy A, Bobashev G, Garbutt JC. (2021) Exploration of the Impact of Combining Risk Phenotypes on the Likelihood of Alcohol Problems in Young Adults. Alcohol and Alcoholism (Oxford, Oxfordshire) |
| Kampov-Polevoy A, Bobashev G, Garbutt JC. (2021) Exploration of the Impact of Combining Risk Phenotypes on the Likelihood of Alcohol Problems in Young Adults. Alcohol and Alcoholism (Oxford, Oxfordshire) |
| Lerma-Cabrera JM, Carvajal F, Garbutt JC, et al. (2019) The melanocortin system as a potential target for treating alcohol use disorders: A review of pre-clinical data. Brain Research. 146628 |
| Proeschold-Bell RJ, Evon DM, Yao J, et al. (2019) A randomized controlled trial of an integrated alcohol reduction intervention in patients with hepatitis C infection. Hepatology (Baltimore, Md.) |
| Garbutt JC. (2019) Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United States. Alcohol and Alcoholism (Oxford, Oxfordshire) |
| Walter TJ, Navarro M, Thiele TE, et al. (2019) A Preliminary, Open-Label Study of Naltrexone and Bupropion Combination Therapy for Treating Binge Drinking in Human Subjects. Alcohol and Alcoholism (Oxford, Oxfordshire) |
| Navarro M, Luhn KL, Kampov-Polevoy AB, et al. (2019) Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice. Alcoholism, Clinical and Experimental Research |
| de Beaurepaire R, Sinclair JMA, Heydtmann M, et al. (2018) The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective. Frontiers in Psychiatry. 9: 708 |
| Agabio R, Sinclair JM, Addolorato G, et al. (2018) Baclofen for the treatment of alcohol use disorder: the Cagliari Statement. The Lancet. Psychiatry |
| Garbutt JC. (2018) Use of Baclofen for Alcohol Use Disorders in the United States. Frontiers in Psychiatry. 9: 448 |